Abstract
The authors investigated the distribution of interleukin-2 receptors (TAC antigen) in the lymph nodes of 300 patients with lymphoproliferative disorders. They used fresh-frozen sections to evaluate a possible correlation between the immunophenotype of specific lymphoid disorders and the presence or absence of TAC expression and to determine whether the TAC positivity of lymphoid cells contributes to the characterization of lymphoproliferative processes. All of the cases had previously been studied with a large screening panel of monoclonal antibodies and polyclonal antisera. Among 85 patients with a variety of benign reactive processes, the lymph nodes from 47 contained TAC-bearing lymphocytes in various patterns of distribution. Of 41 patients with Hodgkin's disease, 37 had TAC-bearing lymphocytes. Of 26 B-cell, well-differentiated lymphocytic lymphomas (WDL), 14 were diffusely TAC-positive and one had TAC-bearing cells in random distribution. Six cases of intermediate lymphocytic lymphoma were also studied, and three showed randomly distributed TAC-bearing lymphocytes. Of 19 patients with follicular or follicular and diffuse, poorly differentiated lymphocytic (PDL) lymphoma, 14 were TAC-positive. All 3 diffuse PDL lymphomas studied were TAC-negative. Among 23 cases of B-cell and 5 cases of T-cell mixed cell lymphoma, 15 and three, respectively, had TAC-positive lymphocytes. Of 39 large cell lymphomas (B-cell, 33; T-cell, 6), 14 were TAC-positive. All 13 cases of hairy cell leukemia were diffusely positive. Of 23 T-lymphoblastic lymphomas, only 1 showed positive TAC reactivity, which was focal. Of 5 cases of cutaneous T-cell lymphoma, 2 had TAC-bearing lymphocytes. Our study indicates that the TAC antigen is not lineage-specific, and that it may be expressed by lymphoid cells regardless of their phenotype.
MeSH Terms
B-Lymphocytes/immunology,metabolism
Cell Differentiation
Cell Division
Hodgkin Disease/immunology,pathology
Humans
Interleukin-2/metabolism
Leprosy/immunology,pathology
Leukemia, Hairy Cell/immunology,pathology
Lymph Nodes/pathology
Lymphocytes/metabolism,pathology
Lymphoma, Non-Hodgkin/immunology,pathology
Lymphoproliferative Disorders/immunology,pathology
Mycosis Fungoides/immunology,pathology
Receptors, Immunologic/metabolism
Receptors, Interleukin-2
Skin/pathology
Spleen/pathology
T-Lymphocytes/immunology,metabolism
Chemicals
Interleukin-2
Receptors, Immunologic
Receptors, Interleukin-2
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sheibani K
Winberg C D
van de Velde S
Blayney D W
Rappaport H
References (21)
21 references, click to expand
-
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.
J Immunol. 1984 Jun;132(6):3085-90
PMID: 6327818
-
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522-6
PMID: 6192435
-
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.
Br J Cancer. 1984 Sep;50(3):415-7
PMID: 6087871
-
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.
J Exp Med. 1984 Oct 1;160(4):1170-83
PMID: 6434689
-
Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.
J Immunol. 1984 Dec;133(6):2996-3000
PMID: 6092463
-
Expression of interleukin 2 receptors on activated human B cells.
J Exp Med. 1984 Nov 1;160(5):1450-66
PMID: 6092511
-
Modulation of human natural killer cell activity by recombinant human interleukin 2.
Cell Immunol. 1985 Feb;90(2):547-54
PMID: 3881192
-
Structural and functional characterization of IL 2 receptors on activated human B cells.
J Immunol. 1985 Apr;134(4):2387-92
PMID: 3919091
-
Induction of IgG secretion in a human B cell clone with recombinant IL 2.
J Immunol. 1985 May;134(5):3104-7
PMID: 3920311
-
Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
J Immunol. 1985 May;134(5):3111-9
PMID: 2580014
-
Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue.
J Immunol. 1985 Jun;134(6):3751-5
PMID: 2985695
-
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
J Immunol. 1985 Jul;135(1):672-8
PMID: 3923116
-
Immunoelectron-microscopic localization of Tac antigen in adult T-cell leukemia/lymphoma.
Am J Pathol. 1985 Jun;119(3):513-6
PMID: 2990220
-
Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation.
Blood. 1985 Sep;66(3):556-61
PMID: 3161562
-
Structure of the human interleukin-2 receptor gene.
Science. 1985 Nov 8;230(4726):633-9
PMID: 2996141
-
The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.
Science. 1986 May 9;232(4751):727-32
PMID: 3008337
-
Enzyme immunohistochemistry: technical aspects.
Semin Diagn Pathol. 1984 Nov;1(4):235-50
PMID: 6086014
-
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.
J Immunol. 1981 Apr;126(4):1398-403
PMID: 6451645
-
A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.
Am J Clin Pathol. 1981 May;75(5):734-8
PMID: 6165237
-
B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells.
J Immunol. 1982 Oct;129(4):1398-402
PMID: 6809822
-
The interleukin-2 T-cell system: a new cell growth model.
Science. 1984 Jun 22;224(4655):1312-6
PMID: 6427923